Integra Lifesciences Holdings (IART) EBT (2016 - 2025)
Historic EBT for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to -$6.8 million.
- Integra Lifesciences Holdings' EBT rose 6648.66% to -$6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$545.3 million, marking a year-over-year decrease of 447480.49%. This contributed to the annual value of -$18.2 million for FY2024, which is 12249.57% down from last year.
- Integra Lifesciences Holdings' EBT amounted to -$6.8 million in Q3 2025, which was up 6648.66% from -$531.0 million recorded in Q2 2025.
- In the past 5 years, Integra Lifesciences Holdings' EBT registered a high of $67.3 million during Q1 2021, and its lowest value of -$531.0 million during Q2 2025.
- Its 5-year average for EBT is -$4.0 million, with a median of $28.9 million in 2023.
- Per our database at Business Quant, Integra Lifesciences Holdings' EBT skyrocketed by 261496.06% in 2021 and then plummeted by 339655.58% in 2025.
- Integra Lifesciences Holdings' EBT (Quarter) stood at $51.8 million in 2021, then grew by 23.98% to $64.2 million in 2022, then crashed by 55.06% to $28.9 million in 2023, then decreased by 21.89% to $22.5 million in 2024, then crashed by 130.27% to -$6.8 million in 2025.
- Its EBT was -$6.8 million in Q3 2025, compared to -$531.0 million in Q2 2025 and -$30.0 million in Q1 2025.